How many stocks are there of Deltagen?
The current number of stocks of Deltagen is 38.85 M undefined.
Deltagen Stocks 2024
Deltagen Stocks
38.85 M
Ticker
DGEN
ISIN
US24783R1032
WKN
938999
In 2024, Deltagen had 38.85 M outstanding stocks, a 0% change from the 38.85 M stocks in the previous year.
The Deltagen Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2015 | 38.85 |
| 2014 | 38.85 |
| 2013 | 38.85 |
| 2012 | 38.85 |
| 2011 | 38.85 |
| 2010 | 38.85 |
| 2006 | 39.22 |
| 2002 | 37.82 |
| 2001 | 29.49 |
| 2000 | 12.62 |
| 1999 | 1.08 |
| 1998 | 0.42 |
| 1997 | 0.42 |
Deltagen shares outstanding US24783R1032 · 938999
3 years
5 years
10 years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Deltagen earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Deltagen's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Deltagen’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Deltagen's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 1997 | 420,000 Aktien |
| 1998 | 420,000 Aktien |
| 1999 | 1.08 M Aktien |
| 2000 | 12.62 M Aktien |
| 2001 | 29.49 M Aktien |
| 2002 | 37.82 M Aktien |
| 2006 | 39.22 M Aktien |
| 2010 | 38.85 M Aktien |
| 2011 | 38.85 M Aktien |
| 2012 | 38.85 M Aktien |
| 2013 | 38.85 M Aktien |
| 2014 | 38.85 M Aktien |
| 2015 | 38.85 M Aktien |
Deltagen Aktienanalyse
What does Deltagen do?
Deltagen Inc is a leading biotechnology company focused on drug discovery and the development of novel therapies. The company was founded in 1996 by a group of scientists and is headquartered in San Francisco, California. The founders recognized the potential of genetic research and developed innovative technologies for identifying target molecules for drug development. Over the years, they acquired numerous patents and heavily invested in research and development. Deltagen Inc specializes in two core areas: genomic research and drug discovery. In the field of genomic research, the company offers services for systematic analysis of gene functions. This includes identification of target molecules, development of drug candidates, and validation of drug targets. In the field of drug discovery, Deltagen Inc focuses on developing novel therapies for a variety of diseases. The company utilizes advanced technologies and innovative research approaches to identify and validate potential drug candidates. Their goal is to develop groundbreaking medications that significantly improve patient's lives. Another important area of Deltagen Inc is diagnostics. The company offers tests for various diseases, including cancer, neurological disorders, and metabolic disorders. These tests are based on genetic analysis and can aid in early detection of diseases and enable targeted treatment. Deltagen Inc works closely with the pharmaceutical industry and other partners to advance drug development. The company has established numerous collaborations and licensing agreements with leading pharmaceutical companies and offers a wide range of products and services for drug development. Deltagen Inc's products include antibodies and other biomolecules that can be used for the treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. The company also develops innovative therapy approaches based on RNA interference and gene therapy. Deltagen Inc is a company with a strong culture of innovation, constantly striving to explore new avenues and evolve. The founders and the entire team have a passion for science and the potential it has for improving the health and well-being of people. Deltagen Inc emphasizes close collaboration with customers and partners to jointly develop and market innovative solutions. The company takes pride in being part of an industry that contributes to improving the lives of patients worldwide. Deltagen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Deltagen's Shares Outstanding
Deltagen's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Deltagen’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Deltagen’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Deltagen’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Deltagen Stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Deltagen are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Deltagen evolved in recent years?
The number of shares of Deltagen has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Deltagen as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Deltagen?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Deltagen pay?
Over the past 12 months, Deltagen paid a dividend of 0.2 USD . This corresponds to a dividend yield of about 200,000 %. For the coming 12 months, Deltagen is expected to pay a dividend of 0 USD.
What is the dividend yield of Deltagen?
The current dividend yield of Deltagen is 200,000 %.
When does Deltagen pay dividends?
Deltagen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Deltagen?
Deltagen paid dividends every year for the past 0 years.
What is the dividend of Deltagen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Deltagen located?
Deltagen is assigned to the '-' sector.
Wann musste ich die Aktien von Deltagen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Deltagen from 5/31/2007 amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on 5/17/2007.
When did Deltagen pay the last dividend?
The last dividend was paid out on 5/31/2007.
What was the dividend of Deltagen in the year 2023?
In the year 2023, Deltagen distributed 0 USD as dividends.
In which currency does Deltagen pay out the dividend?
The dividends of Deltagen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Deltagen
Our stock analysis for Deltagen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Deltagen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.